Spruce Biosciences' Series A Round

Spruce Biosciences raised a round of funding on April 01, 2016.

Spruce Biosciences is a clinical-stage biopharmaceutical focused on developing new treatments for rare endocrine disorders. The company's mission is to develop meaningful therapies for patients with r…

Articles about Spruce Biosciences' Series A Round: